Stanford Researchers Use AI to Identify Natural GLP-1 Alternative
AI-Driven Drug Discovery Targets Natural GLP-1 Pathway
Researchers at Stanford University have applied artificial intelligence to identify a natural compound that could provide the weight-loss and metabolic benefits of GLP-1 receptor agonists like Ozempic and Wegovy, but without the common adverse effects that often lead patients to discontinue treatment.
The